New hope for stroke patients: drug may restore function after medium vessel blockages

NCT ID NCT07047014

Recruiting now Disease control Sponsor: Beijing Tiantan Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether the clot-busting drug tenecteplase can help people who have had a stroke caused by a medium-sized blood vessel blockage in the brain. About 600 participants will receive either tenecteplase or standard care within 4.5 to 24 hours of symptoms starting. The goal is to see if the drug improves recovery and reduces disability at 90 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MEDIUM VESSEL OCCLUSIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MEDIUM VESSEL OCCLUSIONS STROKE, ISCHEMIC

Contacts and locations

Locations

Beijing tiantan hospital
NOT_YET_RECRUITING

Beijing, Beijing Municipality, 100070, China
Hai'an People's Hospital
RECRUITING

Nantong, Jiangsu, 226600, China
Jiuquan city people's hospital
RECRUITING

Jiuquan, Gansu, 736100, China
Jiyuan Traditional Chinese Medicine Hospital
RECRUITING

Jiyuan, Henan, 459000, China
The First Affiliated Hospital, School of Medicine, Zhejiang University
NOT_YET_RECRUITING

Hangzhou, Zhejiang, 310003, China
The first people hospital of lingbao
RECRUITING

Lingbao, Henan, 472500, China
Xingtang People's Hospital
RECRUITING

Shijiazhuang, Hebei, 050600, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.